# FDA Inspection 1111921 - OsteoLife Biomedical, LLC - October 18, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-llc/9ffb5d08-2a16-4d10-b707-7a4cc9351995
Source feed: FDA_Inspections

> FDA Inspection 1111921 for OsteoLife Biomedical, LLC on October 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111921
- Company Name: OsteoLife Biomedical, LLC
- Inspection Date: 2019-10-18
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256937 - 2024-12-11](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-llc/ea77b0fe-3b9a-454f-a543-510a5b09b1e7)
- [FDA Inspection 1256937 - 2024-12-11](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-llc/5ca6fa43-ab1c-48c3-b4f5-3f93366c33a1)
- [FDA Inspection 1028926 - 2017-08-15](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-llc/cd3dde91-ab22-4a06-aa0d-4ae2d3b1502b)
- [FDA Inspection 919494 - 2015-03-26](https://www.globalkeysolutions.net/records/fda_inspections/osteolife-biomedical-llc/acec07b0-9a20-4901-b94e-aa62168445ad)

Company: https://www.globalkeysolutions.net/companies/osteolife-biomedical-llc/c261577a-182d-46e1-a083-3386d3216ec8

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d